39 related articles for article (PubMed ID: 28373463)
1. Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes.
Bista A; Sharma S; Rijwani T; Shah BK
Anticancer Res; 2017 Apr; 37(4):1935-1939. PubMed ID: 28373463
[TBL] [Abstract][Full Text] [Related]
2. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
Kuczmarski TM; Tramontano AC; Mozessohn L; LaCasce AS; Roemer L; Abel GA; Odejide OO
Lancet Haematol; 2023 Jul; 10(7):e530-e538. PubMed ID: 37271158
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
4. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
[TBL] [Abstract][Full Text] [Related]
5. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States.
Yanik EL; Shiels MS; Smith JM; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
Cancer; 2017 Dec; 123(23):4663-4671. PubMed ID: 28759103
[TBL] [Abstract][Full Text] [Related]
6. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.
Gibson TM; Engels EA; Clarke CA; Lynch CF; Weisenburger DD; Morton LM
Am J Hematol; 2014 Jul; 89(7):714-20. PubMed ID: 24753070
[TBL] [Abstract][Full Text] [Related]
7. Cause-specific mortality in a population-level cohort of diffuse large B-cell lymphoma following chemotherapy in the early 21st century.
Bei LY; Shang CY; Wu JZ; Shen HR; Yin H; Liang JH; Zhang XY; Wang L; Li JY; Li Y; Xu W
Ann Hematol; 2024 May; 103(5):1675-1685. PubMed ID: 38228775
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognostic factors for primary pediatric and adolescent Non-Hodgkin Lymphomas of the gastrointestinal tract: a population-based study.
Wu P; Zhu D; Lou Y; Wang X
World J Surg Oncol; 2023 Nov; 21(1):353. PubMed ID: 37968641
[TBL] [Abstract][Full Text] [Related]
9. Racial patterns of patients with primary mediastinal large B-cell lymphoma: SEER analysis.
Liu PP; Wang KF; Xia Y; Bi XW; Sun P; Wang Y; Li ZM; Jiang WQ
Medicine (Baltimore); 2016 Jul; 95(27):e4054. PubMed ID: 27399089
[TBL] [Abstract][Full Text] [Related]
10. Survival of U.S. Military Service Members With Lymphoma.
Ancira G; Romain J; Pham K; Thornton JA; DeStefano CB
Mil Med; 2023 Nov; 188(11-12):e3407-e3410. PubMed ID: 37256781
[TBL] [Abstract][Full Text] [Related]
11. Primary intracranial lymphomas-incidence and survival: a population-based study.
Jiang Y; Zheng X; Lu T; Gao P; Wang Y
Neurosurg Rev; 2023 Oct; 46(1):265. PubMed ID: 37804440
[TBL] [Abstract][Full Text] [Related]
12. Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.
Gong IY; Cheung MC; Chan KKW; Arya S; Faught N; Calzavara A; Liu N; Odejide OO; Abel G; Kurdyak P; Raphael MJ; Kuczmarski T; Prica A; Mozessohn L
J Natl Cancer Inst; 2023 Oct; 115(10):1194-1203. PubMed ID: 37531271
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcome and Prognostic Factors of Primary Spinal Cord Lymphoma.
Qianjin D; Zhenguo C; Yang W; Baoshun D; Laiguang S
Turk Neurosurg; 2024; 34(2):216-223. PubMed ID: 38497173
[TBL] [Abstract][Full Text] [Related]
14. Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study.
Di M; Keeney T; Belanger E; Panagiotou OA; Olszewski AJ
JCO Oncol Pract; 2022 Mar; 18(3):e383-e402. PubMed ID: 34846916
[TBL] [Abstract][Full Text] [Related]
15. Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Kühnl A; Cunningham D; Counsell N; Hawkes EA; Qian W; Smith P; Chadwick N; Lawrie A; Mouncey P; Jack A; Pocock C; Ardeshna KM; Radford J; McMillan A; Davies J; Turner D; Kruger A; Johnson PW; Gambell J; Rosenwald A; Ott G; Horn H; Ziepert M; Pfreundschuh M; Linch D
Ann Oncol; 2017 Jul; 28(7):1540-1546. PubMed ID: 28398499
[TBL] [Abstract][Full Text] [Related]
16. A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Czuczman MS; Trněný M; Davies A; Rule S; Linton KM; Wagner-Johnston N; Gascoyne RD; Slack GW; Brousset P; Eberhard DA; Hernandez-Ilizaliturri FJ; Salles G; Witzig TE; Zinzani PL; Wright GW; Staudt LM; Yang Y; Williams PM; Lih CJ; Russo J; Thakurta A; Hagner P; Fustier P; Song D; Lewis ID
Clin Cancer Res; 2017 Aug; 23(15):4127-4137. PubMed ID: 28381416
[No Abstract] [Full Text] [Related]
17. Lymphoma classification update: B-cell non-Hodgkin lymphomas.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 May; 10(5):405-415. PubMed ID: 28395545
[TBL] [Abstract][Full Text] [Related]
18. Primary lymphoma of bone: a population-based study of 2558 patients.
Liu CX; Xu TQ; Xu L; Wang PP; Cao C; Gao GX; Zheng YH
Ther Adv Hematol; 2020; 11():2040620720958538. PubMed ID: 32994912
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell Lymphoma.
Zhao J; Su L; Zhong J
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e858-e863. PubMed ID: 32680777
[TBL] [Abstract][Full Text] [Related]
20. Recent survival trends in diffuse large B-cell lymphoma--Have we made any progress beyond rituximab?
Epperla N; Vaughn JL; Othus M; Hallack A; Costa LJ
Cancer Med; 2020 Aug; 9(15):5519-5525. PubMed ID: 32558356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
